Kestra Medical Technologies (KMTS) Depreciation & Amortization (CF) (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $2.3 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 26.63% year-over-year to $2.3 million in Q2 2026; TTM through Apr 2026 was $8.7 million, a 9.3% increase from a year earlier, with the FY2026 full-year figure at $8.7 million, up 9.3% from the prior year.
• Depreciation & Amortization (CF) for Q2 2026 stood at $2.3 million, up from $2.0 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for KMTS reached as high as $3.5 million in Q2 2024 and fell as low as $1.8 million in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $2.4 million across 3 years, with a median of $2.2 million in 2025.
• On a YoY basis, Depreciation & Amortization (CF) climbed as much as 26.97% in 2025 and fell as far as 47.57% in 2025.
• Year by year, Depreciation & Amortization (CF) stood at $1.9 million in 2024, then climbed by 26.97% to $2.4 million in 2025, then retreated by 2.02% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2.3 million in Q2 2026, $2.0 million in Q1 2026, and $2.4 million in Q4 2025.